Use of Gadolinium in Individuals with Reduced Kidney Function.
作者信息
Kalantari Kambiz, Swaminathan Sundararaman
机构信息
Division of Nephrology, University of Virginia Health System, Charlottesville, Virginia.
Division of Nephrology, Mayo Clinic Arizona, Phoenix, Arizona.
出版信息
Clin J Am Soc Nephrol. 2021 Feb 8;16(2):304-306. doi: 10.2215/CJN.13950820. Epub 2021 Jan 11.
Abstract
摘要
相似文献
1
Use of Gadolinium in Individuals with Reduced Kidney Function.
Clin J Am Soc Nephrol. 2021 Feb 8;16(2):304-306. doi: 10.2215/CJN.13950820. Epub 2021 Jan 11.
2
Gadolinium in pediatric cardiovascular magnetic resonance: what we know and how we practice.
J Cardiovasc Magn Reson. 2012 Aug 7;14(1):56. doi: 10.1186/1532-429X-14-56.
3
Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging.
Clin J Am Soc Nephrol. 2010 Mar;5(3):484-9. doi: 10.2215/CJN.06580909. Epub 2010 Jan 21.
4
Gadolinium-Induced Fibrosis.
Annu Rev Med. 2016;67:273-91. doi: 10.1146/annurev-med-063014-124936.
5
Gadolinium-induced NSF claim resolved in favor of plaintiff.
J Med Assoc Ga. 2012;101(3):32-3.
6
Prospective Cohort Study of Nephrogenic Systemic Fibrosis in Patients With Stage 3-5 Chronic Kidney Disease Undergoing MRI With Injected Gadobenate Dimeglumine or Gadoteridol.
AJR Am J Roentgenol. 2015 Sep;205(3):469-78. doi: 10.2214/AJR.14.14268.
7
Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis.
JAMA Intern Med. 2020 Feb 1;180(2):223-230. doi: 10.1001/jamainternmed.2019.5284.
8
Nephrogenic systemic fibrosis.
Magn Reson Imaging Clin N Am. 2009 Feb;17(1):159-67. doi: 10.1016/j.mric.2009.01.003.
9
Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities.
Radiology. 2009 Dec;253(3):689-96. doi: 10.1148/radiol.2533090649. Epub 2009 Sep 29.
10
Prophylactic Hemodialysis for Protection Against Gadolinium-Induced Nephrogenic Systemic Fibrosis: A Doll's House.
Adv Chronic Kidney Dis. 2017 May;24(3):133-135. doi: 10.1053/j.ackd.2017.03.007.
Zotero 插件